Page last updated: 2024-08-21

ethambutol and ciprofloxacin

ethambutol has been researched along with ciprofloxacin in 130 studies

Research

Studies (130)

Timeframe	Studies, this research(%)	All Research%
pre-1990	2 (1.54)	18.7374
1990's	33 (25.38)	18.2507
2000's	25 (19.23)	29.6817
2010's	60 (46.15)	24.3611
2020's	10 (7.69)	2.80

Authors

Authors	Studies
Sriram, D; Thirumurugan, R; Yogeeswari, P	1
Christiansen, HC; Copp, BR; G Franzblau, S; Lindsay, BS	1
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL	1
Cho, SH; Franzblau, SG; Hwang, CH; Pauli, GF; Wan, B; Warit, S	1
Andricopulo, AD; Moda, TL; Montanari, CA	1
Lombardo, F; Obach, RS; Waters, NJ	1
Connell, TG; Curtis, N; Ritz, N; Robins-Browne, R; Sievers, A; Tebruegge, M	1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV	1
Gaillard, JL; Jackson, M; McDonnell, G; Niederweis, M; Skovierová, H; Svetlíková, Z	1
Dempsey, S; Jack, C; Miller, CH; Nisa, S; O'Toole, R	1
Banerjee, D; Kumar, RS; Perumal, S; Rajesh, SM; Sriram, D; Yogeeswari, P	1
Kumar, RS; Perumal, S; Shetty, KA; Sriram, D; Yogeeswari, P	1
Campillo, NE; Guerra, A; Páez, JA	1
Kumar, P; Narasimhan, B; Sriram, D; Yogeeswari, P	1
Balamurugan, K; Perumal, S; Prasanna, P; Sriram, D; Yogeeswari, P	1
Balamurugan, K; Maheswari, SU; Perumal, S; Sriram, D; Yogeeswari, P	1
Bauer, R; Blunder, M; Bucar, F; Hüfner, A; Kollroser, M; Thomaschitz, C; Wube, AA	1
Briguglio, I; Carta, A; Corona, P; Guglierame, P; Jabes, D; Molicotti, P; Palomba, M; Piras, S; Zanetti, S	1
Chiba, T; Hasegawa, T; Horita, Y; Kremer, L; Kuroishi, R; Lee, Y; Ogawa, K; Onozaki, K; Sato, Y; Takii, T	1
Bauer, R; Blunder, M; Bucar, F; Hochfellner, C; Hüfner, A; Wube, AA	1
Kumar, RS; Libertsen, LA; Perumal, S; Rajesh, SM; Sriram, D; Yogeeswari, P	1
Kalivendi, SV; Raju, BC; Rao, RN; Shaik, TB; Sriram, D; Suman, P; Yogeeswari, P	1
Menéndez, JC; Perumal, S; Ranjith Kumar, R; Sriram, D; Yogeeswari, P	1
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V	1
Perumal, S; Raja, VP; Sriram, D; Yogeeswari, P	1
Gunasekaran, P; Perumal, S; Sriram, D; Yogeeswari, P	1
Chitra, S; Manisankar, P; Muthusubramanian, S; Paul, N; Sriram, D; Yogeeswari, P	2
Murugavel, M; Muthusubramanian, S; Paul, N; Sriram, D	1
Constant, P; Daffé, M; Massimba Dibama, H; Mourer, M; Regnouf-de-Vains, JB	1
Bucar, F; Gröblacher, B; Kunert, O	1
Chikhalia, KH; Kumari, P; Patel, PK; Patel, RV; Rajani, DP	1
Almansour, AI; Arumugam, N; Sriram, D; Suresh Kumar, R	1
Nallangi, R; Samala, G; Sridevi, JP; Sriram, D; Yogeeswari, P	1
Balkan, A; Dharmarajan, S; Ozadali, K; Tan, OU; Yogeeswari, P	1
Basireddy, VS; Dharmarajan, S; Guttala, RS; Jagarlamudi, PS; Mukkara, LD; Pagadala, LR; Perumal, Y; Ravirala, N; Singh, A; Singireddi, S; Thummaluru, VR; Ummanni, R; Upadhyayula, SM	1
Dayakar, C; Rajkumar, K; Raju, BC; Rao, JV; Sriram, D; Suman, P; Yashwanth, B; Yogeeswari, P	1
Kamal, A; Ravikumar, A; Reddy, BV; Sravanthi, G; Sridevi, B; Sridevi, JP; Sriram, D; Venkateswarlu, A; Yogeeswari, P	1
Constant, P; Daffé, M; Massimba-Dibama, H; Mourer, M; Regnouf-de-Vains, JB	1
Askri, M; Boudriga, S; Golz, C; Knorr, M; Mhiri, C; Nana, F; Sriram, D; Strohmann, C; Yogeeswari, P	1
Dalimba, U; Nayak, N; Ramprasad, J	2
Aminabhavi, TM; Dixit, SR; Joshi, SD; Kirankumar, MN; Lherbet, C; Narayan, R; Raju, KV; Yang, KS	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Chakraborti, AK; Dhameliya, TM; Jadhavar, PS; Pancholia, S; Shah, P; Sridevi, JP; Sriram, D; Yogeshwari, P	1
Chakraborti, AK; Dhameliya, TM; Jadhavar, PS; Kumar, D; Sridevi, JP; Sriram, D; Vaja, MD; Yogeeswari, P	1
Jones, LH; Nadanaciva, S; Rana, P; Will, Y	1
Chakraborti, AK; Kumar, A; Sriram, D; Tanwar, B; Yogeeswari, P	1
Aminabhavi, TM; Dixit, SR; Joshi, SD; Kulkarni, VH; Lherbet, C; Nadagouda, MN	1
Balaji, NV; Hari Babu, B; Murali Krishna Kumar, M; Purna Nagasree, K; Subbaraju, GV	1
Adhikari, C; Krishna, VS; Reshma, RS; Sharada, DS; Sriram, D; Vidyacharan, S	1
Bimal, D; Bohra, K; Jain, R; Maity, J; Ponnan, P; Prasad, AK; Singh, B; Srivastava, S; Thirumal, M; Varma-Basil, M	1
Banerjee, A; Chakraborti, AK; Dhameliya, TM; Pancholia, S; Panda, D; Sriram, D; Tiwari, R	1
Ashok, D; Goud, GL; Manga, V; Ramesh, S; Reddy, VP; Saikrishna, B; Sriram, D; Yogeeswari, P	1
Dogonadze, M; Kraeva, L; Krasavin, M; Lukin, A; Manicheva, O; Rogacheva, E; Vedekhina, T; Vinogradova, T; Yablonsky, P; Zabolotnykh, N	1
Bai, L; Deng, JL; Gao, F; Lv, ZS; Wang, Y; Xu, Z; Zhang, F; Zhao, SJ	1
AnkiReddy, S; Bharathi Reddy, K; Rao Sagurthi, S; Sabitha, G; Shiva Raju, K; Siva Krishna, V; Sriram, D	1
Kantevari, S; Krishna, VS; Marvadi, SK; Sriram, D	2
Akhter, M; Alam, MM; Ali, S; Deora, GS; Krishna, VS; Sharma, K; Sriram, D; Tanwar, O; Zaman, MS	1
Bera, S; Mondal, D	1
Esaulkova, YL; Kantevari, S; Krishna, VS; Marvadi, SK; Muryleva, AA; Sinegubova, EO; Sriram, D; Tentler, DG; Volobueva, AS; Zarubaev, VV	1
Augustynowicz-Kopeć, E; Bielenica, A; Chrzanowska, A; Dobrowolski, M; Głogowska, A; Roszkowski, P; Stępień, K; Struga, M; Szulczyk, D	1
Bangalore, PK; Bollikanda, RK; Choudante, PC; Kantevari, S; Misra, S; Sridhar, B; Sriram, D; Vagolu, SK; Veeragoni, DK	1
Krishna, VS; Sirim, MM; Sriram, D; Unsal Tan, O	1
Dixit, PP; Haval, KP; Haval, NB; Kasare, SL; Khedkar, VM; Patil, PS; Rekha, EM; Sriram, D	1
Behera, JN; Konduri, S; Krishna, VS; Prashanth, J; Rao, KP; Siegel, D; Sriram, D	1
Bakale, RD; Dhumal, ST; Dixit, PP; Haval, KP; Khedkar, VM; Krishna, VS; Kulkarni, RS; Phatak, PS; Sriram, D	1
Cordeiro, R; Kachroo, M	1
Trotsko, N	1
Ahmad, I; Alshahrani, MY; Jain, R; Pradeep Kumar, CB; Prashanth, MK; Raghu, MS; Yogesh Kumar, K	1
Agrahari, AK; Rajkhowa, S; Sharma, A; Tiwari, VK	1
Hjelm, U; Hoffner, SE; Kaustová, J; Kubín, M	1
Bollet, C; de Micco, P; Gevaudan, MJ; Mallet, MN	1
Bartok, AE; Chiu, J; Deresinski, SC; Feigal, DF; Kemper, CA; Leedom, JM; McCutchan, JA; Meng, TC; Nussbaum, J; Tilles, JG	1
Benson, CA; Kessler, HA; Pottage, JC; Trenholme, GM	1
Hadley, WK; Nassos, PS; Sanders, CA; Yajko, DM	1
Bozzette, S; Chiu, J; Heseltine, PN; Leedom, J; McCutchan, JA; Nussbaum, J; Tilles, JG; Young, LS	1
Hoffner, SE; Källenius, G; Kratz, M; Olsson-Liljequist, B; Svenson, SB	1
Collins, CH; Uttley, AH	1
Nelson, SD; Nolan, CM; Sandblom, RE; Slattery, JT; Thummel, KE	1
Simonetti, MT; Tortoli, E	1
Greten, T; Hautmann, H; Huber, RM; Trauner, A	1
Ahn, CH; Brown, BA; Dunbar, D; Dunlap, R; Murphy, DT; Onyi, G; Wallace, RJ	1
Gordon, SM; Havlik, JA; Heifets, L; Horsburgh, CR; McGowan, JE; Metchock, B; Peloquin, CA; Thompson, SE	1
Fox, R; Gillespie, SH; Kennedy, N; Kisyombe, GM; Ngowi, FI; Ramsay, AR; Saruni, AO; Uiso, LO	1
Hjelm, U; Hoffner, SE; Källenius, G	1
Clark, JA; Margolis, DM	1
Brosgart, C; Charlebois, E; Gary, D; Hadley, WK; Jacobson, MA; Northfelt, D; Sanders, CA; Yajko, D	1
Asnis, DS; Bresciani, AR; Cohn, M	1
Fanning, MM; Fong, IW; Gill, MJ; Lalonde, RG; Phillips, P; Rachlis, AR; Salit, I; Shafran, SD; Singer, J; Tsoukas, CM; Walmsley, SL; Zarowny, DP	1
Berger, L; Curram, J; Fox, R; Gillespie, SH; Gutmann, J; Kennedy, N; Kisyombe, GM; Ngowi, FI; Ramsay, AR; Sam, N; Saruni, AO; Tillotson, G; Uiso, LO; Yates, M	1
Coker, RJ; Fisher, M; Tomlinson, DR	1
Benator, DA; Gordin, FM; Kan, V	1
Fuursted, K	1
Koga, H; Kohno, S; Miyamoto, J; Ogawa, K; Ohno, H; Tashiro, T; Tomono, K	1
Popov, VL; Reisner, BS; Woods, GL	1
Barzilai, A; Blank-Porat, D; Keller, N; Levi, I; Rubinovich, B; Rubinstein, E	1
Kerharo, G; Matsiota-Bernard, P; Nauciel, C; Vrioni, G	1
Barber, TW; Currier, J; Ellner, JJ; Hafner, R; Hojczyk, P; Hooton, TM; Jacobs, MR; Limjoco, M; Parenti, DM; Powderly, WG; Simpson, G; van der Horst, C; Williams, PL	1
Dubé, MP; Havlir, DV; Kemper, CA; Leedom, JM; McCutchan, JA; Sattler, FR; See, D; Tilles, JG; Torriani, FJ	1
Chang, SC; Chang, YL; Fang, CT; Hsieh, WC; Hsueh, PR; Luh, KT	1
Drobniewski, FA; Eltringham, IJ; Wilson, SM	1
Koromihis, G; Libman, M; MacLean, JD; Semret, M; Ward, BJ	1
Bartsch, P; Corhay, JL; Gach, O; Lousberg, L	1
Keiser, P; Nassar, N; Rademacher, S; Skiest, D; Smith, JW	1
Khorasheh, S; Lemieux, C; Raboud, JM; Salit, I; Shafran, SD; Singer, J; Thorne, A; Tsoukas, CM; Wu, AW	1
Bajaksouzian, S; Jacobs, MR; Joloba, ML	1
Böcher, W; Galle, PR; Märker-Hermann, E	1
Carbonell, D; Fernández-Olivera, N; García-García, I; López-Saura, PA; Machado-Molina, D; Milanés-Virelles, MT; Suárez-Méndez, R; Valdés-Quintana, M; Valenzuela-Silva, CM	1
Abo, M; Fujimura, M; Honjyo, C; Nakao, S; Nishizawa, Y; Tagami, A; Yasui, M	1
Baek, DH; Chung, MJ; Ha, NJ; Kang, BY; Kang, JY; Kim, K; Kim, SD; Shin, EA; Yim, DS; Yun, JH	1
Bhusal, Y; Shiohira, CM; Yamane, N	1
Chimara, E; da Silva Telles, MA; Ferrazoli, L; Riley, LW	1
Baum, GL; Daniele, B; Kramer, MR; Lavy, A; Priess, R; Raz, M; Shitrit, AB; Shitrit, D; Shlomi, D	1
Bermúdez-Ruiz, P; de la Quintana-Beltrán, P; Pérez de Pedro, I	1
Cefalo, E; Cugliari, M; Martín, M; Valerga, M	1
Banks, J; Campbell, IA; Gelder, CM; Jenkins, PA; Prescott, RJ; Smith, AP	1
Hill, AT; Laurenson, IF; Murray, MP	1
Booth, F; Gottlieb, T; Janarthanan, P; Karim, R; McCarthy, S; Merani, R; Orekondy, S	1
Cedidi, C; Dabernig, J; Ingianni, G; Nenadic, I; Schumacher, O	1
Campbell, PJ; Cowan, LS; Dalton, TL; Hooks, DP; Metchock, B; Morlock, GP; Plikaytis, BB; Posey, JE; Sikes, RD; Starks, AM	1
Ambrose, PG; Bhavnani, SM; Caws, M; Chau, TT; Dung, NT; Farrar, J; Hammel, JP; Hien, TT; Kulawy, R; Mai, PP; Reynolds, DK; Thwaites, GE; Török, ME; Van Wart, SA	1
Chitnis, DS; Hemvani, N; Patidar, V	2
Patsche, CB; Svensson, E; Wejse, C	1
Abdelmalek, R; Amor, MB; Benaissa, HT; Berriche, A; Besbes, G; Chahed, H; Hachicha, H; Kilani, B; Mediouni, A	1
Al-Busaidi, I; Boggild, AK; Wong, D	1
Clifton, DA; Crook, DW; Iqbal, Z; Niehaus, KE; Peto, TEA; Smith, EG; Walker, AS; Walker, TM; Wilson, DJ; Yang, Y; Zhu, T	1

Reviews

8 review(s) available for ethambutol and ciprofloxacin

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016
Fluoroquinolone-isatin hybrids and their biological activities. European journal of medicinal chemistry, 2019, Jan-15, Volume: 162 Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antineoplastic Agents; Antitubercular Agents; Antiviral Agents; Fluoroquinolones; Humans; Isatin; Structure-Activity Relationship	2019
Insights of synthetic analogues of anti-leprosy agents. Bioorganic & medicinal chemistry, 2019, 07-01, Volume: 27, Issue:13 Topics: Humans; Leprostatic Agents; Leprosy; Structure-Activity Relationship	2019
Antitubercular properties of thiazolidin-4-ones - A review. European journal of medicinal chemistry, 2021, Apr-05, Volume: 215 Topics: Animals; Antitubercular Agents; Chlorocebus aethiops; Humans; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium; Structure-Activity Relationship; Thiazolidines; THP-1 Cells; Vero Cells	2021
Emerging impact of triazoles as anti-tubercular agent. European journal of medicinal chemistry, 2022, Aug-05, Volume: 238 Topics: Antitubercular Agents; Humans; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Structure-Activity Relationship; Triazoles; Tuberculosis	2022
[Esophagomediastinal fistulae as a rare complication of tuberculosis in an HIV-infected patient]. Deutsche medizinische Wochenschrift (1946), 1994, Nov-25, Volume: 119, Issue:47 Topics: AIDS-Related Opportunistic Infections; Ciprofloxacin; Drug Therapy, Combination; Esophageal Fistula; Ethambutol; Fistula; HIV-1; Humans; Male; Mediastinal Diseases; Middle Aged; Pyrazinamide; Rifampin; Tuberculosis, Lymph Node	1994
Mycobacterium szulgai infection of the lung: case report and review of an unusual pathogen. The American journal of the medical sciences, 1997, Volume: 313, Issue:6 Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Lung Diseases; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium; Mycobacterium Infections; Radiography; Rifampin	1997
Successful treatment of disseminated Mycobacterium szulgai infection with ciprofloxacin, rifampicin, and ethambutol. The Journal of infection, 1999, Volume: 38, Issue:3 Topics: Adolescent; Aged; Anti-Infective Agents; Antibiotics, Antitubercular; Ciprofloxacin; Drug Therapy, Combination; Ethambutol; Humans; Male; Middle Aged; Mycobacterium Infections; Nontuberculous Mycobacteria; Rifampin	1999

Trials

12 trial(s) available for ethambutol and ciprofloxacin

Article	Year
Treatment of Mycobacterium avium complex bacteremia in AIDS with a four-drug oral regimen. Rifampin, ethambutol, clofazimine, and ciprofloxacin. The California Collaborative Treatment Group. Annals of internal medicine, 1992, Mar-15, Volume: 116, Issue:6 Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Adult; Amikacin; Anti-Infective Agents; Bacteremia; Ciprofloxacin; Clofazimine; Colony Count, Microbial; Drug Evaluation; Drug Therapy, Combination; Ethambutol; Female; Follow-Up Studies; Humans; Male; Middle Aged; Mycobacterium avium-intracellulare Infection; Prospective Studies; Rifampin	1992
Early bactericidal and sterilizing activities of ciprofloxacin in pulmonary tuberculosis. The American review of respiratory disease, 1993, Volume: 148, Issue:6 Pt 1 Topics: Adult; Aged; Ciprofloxacin; Drug Therapy, Combination; Ethambutol; Female; HIV Seropositivity; HIV-1; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Prospective Studies; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary	1993
Randomized, placebo-controlled trial of rifampin, ethambutol, and ciprofloxacin for AIDS patients with disseminated Mycobacterium avium complex infection. The Journal of infectious diseases, 1993, Volume: 168, Issue:1 Topics: Adult; AIDS-Related Opportunistic Infections; Ciprofloxacin; Double-Blind Method; Drug Synergism; Drug Therapy, Combination; Ethambutol; Female; Humans; Male; Middle Aged; Mycobacterium avium-intracellulare Infection; Rifampin	1993
A comparison of two regimens for the treatment of Mycobacterium avium complex bacteremia in AIDS: rifabutin, ethambutol, and clarithromycin versus rifampin, ethambutol, clofazimine, and ciprofloxacin. Canadian HIV Trials Network Protocol 010 Study Group. The New England journal of medicine, 1996, Aug-08, Volume: 335, Issue:6 Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Antitubercular Agents; Bacteremia; Ciprofloxacin; Clarithromycin; Clofazimine; Drug Therapy, Combination; Ethambutol; Female; Humans; Male; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Rifabutin; Rifampin; Survival Analysis; Treatment Outcome; Uveitis	1996
Randomized controlled trial of a drug regimen that includes ciprofloxacin for the treatment of pulmonary tuberculosis. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1996, Volume: 22, Issue:5 Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Infective Agents; Antitubercular Agents; Ciprofloxacin; Ethambutol; Female; HIV-1; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Rifampin; Time Factors; Tuberculosis, Pulmonary	1996
A phase II/III trial of antimicrobial therapy with or without amikacin in the treatment of disseminated Mycobacterium avium infection in HIV-infected individuals. AIDS Clinical Trials Group Protocol 135 Study Team. AIDS (London, England), 1998, Dec-24, Volume: 12, Issue:18 Topics: Adult; AIDS-Related Opportunistic Infections; Amikacin; Bacteremia; Ciprofloxacin; Clofazimine; Colony Count, Microbial; Drug Therapy, Combination; Ethambutol; Female; Humans; Male; Microbial Sensitivity Tests; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Rifampin	1998
Successful short-term suppression of clarithromycin-resistant Mycobacterium avium complex bacteremia in AIDS. California Collaborative Treatment Group. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1999, Volume: 28, Issue:1 Topics: AIDS-Related Opportunistic Infections; Bacteremia; Ciprofloxacin; Clarithromycin; Clofazimine; Drug Resistance, Microbial; Drug Therapy, Combination; Ethambutol; Humans; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Rifabutin	1999
Symptomatic and health status outcomes in the Canadian randomized MAC treatment trial (CTN010). Canadian HIV Trials Network Protocol 010 Study Group. International journal of STD & AIDS, 2000, Volume: 11, Issue:4 Topics: Adolescent; Adult; AIDS-Related Opportunistic Infections; Antitubercular Agents; Bacteremia; Canada; Ciprofloxacin; Clarithromycin; Clofazimine; Drug Therapy, Combination; Ethambutol; Health Status; Humans; Mycobacterium avium-intracellulare Infection; Outcome and Process Assessment, Health Care; Rifabutin; Rifampin; Treatment Outcome	2000
Adjuvant interferon gamma in patients with drug - resistant pulmonary tuberculosis: a pilot study. BMC infectious diseases, 2004, Oct-22, Volume: 4 Topics: Adjuvants, Immunologic; Adult; Amikacin; Antitubercular Agents; Ciprofloxacin; Drug Resistance, Bacterial; Drug Therapy, Combination; Ethambutol; Ethionamide; Female; Follow-Up Studies; Humans; Interferon-gamma; Kanamycin; Male; Middle Aged; Mycobacterium tuberculosis; Pilot Projects; Pyrazinamide; Radiography; Recombinant Proteins; Rifampin; Sputum; Treatment Outcome; Tuberculosis, Pulmonary	2004
Clarithromycin vs ciprofloxacin as adjuncts to rifampicin and ethambutol in treating opportunist mycobacterial lung diseases and an assessment of Mycobacterium vaccae immunotherapy. Thorax, 2008, Volume: 63, Issue:7 Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Antitubercular Agents; Ciprofloxacin; Clarithromycin; Drug Therapy, Combination; Ethambutol; Female; Humans; Immunotherapy; Male; Middle Aged; Opportunistic Infections; Rifampin; Tuberculosis, Pulmonary	2008
Outcomes of a standardized triple-drug regimen for the treatment of nontuberculous mycobacterial pulmonary infection. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2008, Jul-15, Volume: 47, Issue:2 Topics: Aged; Anti-Bacterial Agents; Blood Sedimentation; Ciprofloxacin; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Ethambutol; Female; Humans; Lung; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium avium; Mycobacterium avium-intracellulare Infection; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Radiography; Rifampin; Sputum; Treatment Outcome; Tuberculosis, Pulmonary	2008
Randomized pharmacokinetic and pharmacodynamic comparison of fluoroquinolones for tuberculous meningitis. Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:7 Topics: Administration, Oral; Adolescent; Adult; Aged; Ciprofloxacin; Ethambutol; Female; Fluoroquinolones; Gatifloxacin; Humans; Injections, Intramuscular; Isoniazid; Levofloxacin; Male; Middle Aged; Multivariate Analysis; Ofloxacin; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis, Meningeal; Young Adult	2011

Other Studies

110 other study(ies) available for ethambutol and ciprofloxacin

Article	Year
Antituberculous activity of some aryl semicarbazone derivatives. Bioorganic & medicinal chemistry letters, 2004, Aug-02, Volume: 14, Issue:15 Topics: Antitubercular Agents; Microbial Sensitivity Tests; Molecular Conformation; Molecular Structure; Mycobacterium tuberculosis; Semicarbazones; Structure-Activity Relationship	2004
Identification of heteroarylenamines as a new class of antituberculosis lead molecules. Bioorganic & medicinal chemistry letters, 2005, Sep-15, Volume: 15, Issue:18 Topics: Amines; Antitubercular Agents; Drug Evaluation, Preclinical; Drug Resistance; Inhibitory Concentration 50; Molecular Structure; Mycobacterium tuberculosis; Structure-Activity Relationship	2005
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling. Current drug discovery technologies, 2004, Volume: 1, Issue:4 Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration	2004
Low-oxygen-recovery assay for high-throughput screening of compounds against nonreplicating Mycobacterium tuberculosis. Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:4 Topics: Anti-Bacterial Agents; Antitubercular Agents; DNA, Bacterial; Drug Evaluation, Preclinical; Mycobacterium tuberculosis; Oxygen	2007
Hologram QSAR model for the prediction of human oral bioavailability. Bioorganic & medicinal chemistry, 2007, Dec-15, Volume: 15, Issue:24 Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship	2007
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7 Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding	2008
Susceptibility of Mycobacterium bovis BCG vaccine strains to antituberculous antibiotics. Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:1 Topics: Antitubercular Agents; BCG Vaccine; Microbial Sensitivity Tests; Mycobacterium bovis	2009
Physicochemical determinants of human renal clearance. Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15 Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight	2009
Role of porins in the susceptibility of Mycobacterium smegmatis and Mycobacterium chelonae to aldehyde-based disinfectants and drugs. Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:9 Topics: Antitubercular Agents; Disinfectants; Drug Resistance, Bacterial; Glutaral; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation; Mycobacterium chelonae; Mycobacterium smegmatis; o-Phthalaldehyde; Porins	2009
Modifying culture conditions in chemical library screening identifies alternative inhibitors of mycobacteria. Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:12 Topics: Antitubercular Agents; Cysteine; Drug Evaluation, Preclinical; Mycobacterium; Mycobacterium smegmatis; Organoselenium Compounds; Selenocysteine; Small Molecule Libraries	2009
Novel three-component domino reactions of ketones, isatin and amino acids: synthesis and discovery of antimycobacterial activity of highly functionalised novel dispiropyrrolidines. European journal of medicinal chemistry, 2010, Volume: 45, Issue:1 Topics: Amino Acids; Anti-Bacterial Agents; Isatin; Ketones; Microbial Sensitivity Tests; Models, Molecular; Molecular Conformation; Mycobacterium tuberculosis; Pyrrolidines	2010
1,3-Dipolar cycloaddition of C-aryl-N-phenylnitrones to (R)-1-(1-phenylethyl)-3-[(E)-arylmethylidene]tetrahydro-4(1H)-pyridinones: synthesis and antimycobacterial evaluation of enantiomerically pure spiroisoxazolidines. European journal of medicinal chemistry, 2010, Volume: 45, Issue:1 Topics: Anti-Bacterial Agents; Drug Discovery; Microbial Sensitivity Tests; Models, Molecular; Molecular Conformation; Mycobacterium tuberculosis; Nitrogen Oxides; Oxazoles; Pyridones; Stereoisomerism	2010
Neural computational prediction of oral drug absorption based on CODES 2D descriptors. European journal of medicinal chemistry, 2010, Volume: 45, Issue:3 Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical	2010
Synthesis and antitubercular activities of substituted benzoic acid N'-(substituted benzylidene/furan-2-ylmethylene)-N-(pyridine-3-carbonyl)-hydrazides. European journal of medicinal chemistry, 2010, Volume: 45, Issue:12 Topics: Antitubercular Agents; Benzoic Acid; Dose-Response Relationship, Drug; Hydrazones; Molecular Structure; Mycobacterium tuberculosis; Stereoisomerism; Structure-Activity Relationship	2010
A regio- and stereoselective 1,3-dipolar cycloaddition for the synthesis of novel spiro-pyrrolothiazolyloxindoles and their antitubercular evaluation. European journal of medicinal chemistry, 2010, Volume: 45, Issue:12 Topics: Antitubercular Agents; Cyclization; Indoles; Microbial Sensitivity Tests; Molecular Conformation; Mycobacterium tuberculosis; Oxindoles; Spiro Compounds; Stereoisomerism	2010
A facile 1,3-dipolar cycloaddition of azomethine ylides to 2-arylidene-1,3-indanediones: synthesis of dispiro-oxindolylpyrrolothiazoles and their antimycobacterial evaluation. Bioorganic & medicinal chemistry letters, 2010, Dec-15, Volume: 20, Issue:24 Topics: Antitubercular Agents; Azo Compounds; Crystallography, X-Ray; Indans; Microbial Sensitivity Tests; Molecular Conformation; Mycobacterium tuberculosis; Spiro Compounds; Stereoisomerism; Thiazoles; Thiosemicarbazones	2010
Design, synthesis and antimycobacterial activities of 1-methyl-2-alkenyl-4(1H)-quinolones. Bioorganic & medicinal chemistry, 2011, Jan-01, Volume: 19, Issue:1 Topics: Antitubercular Agents; Cell Line; Drug Screening Assays, Antitumor; Humans; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Quinolones	2011
Synthesis and anti-mycobacterial activities of triazoloquinolones. European journal of medicinal chemistry, 2011, Volume: 46, Issue:1 Topics: Anti-Bacterial Agents; Candida; Cell Line, Tumor; Humans; Microbial Sensitivity Tests; Mycobacterium; Quinolones	2011
Synthesis and evaluation of anti-tubercular activity of new dithiocarbamate sugar derivatives. Bioorganic & medicinal chemistry letters, 2011, Feb-01, Volume: 21, Issue:3 Topics: Antitubercular Agents; Carbohydrates; Drug Resistance, Bacterial; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Oxidoreductases; Thiocarbamates; Thioglucosides	2011
Synthesis of N-substituted 2-[(1E)-alkenyl]-4-(1H)-quinolone derivatives as antimycobacterial agents against non-tubercular mycobacteria. European journal of medicinal chemistry, 2011, Volume: 46, Issue:6 Topics: Anti-Bacterial Agents; Cell Line; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Humans; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium; Quinolones; Stereoisomerism; Structure-Activity Relationship	2011
A green expedient synthesis of pyridopyrimidine-2-thiones and their antitubercular activity. Bioorganic & medicinal chemistry letters, 2011, May-15, Volume: 21, Issue:10 Topics: Antitubercular Agents; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Pyrimidines; Thiones	2011
Synthesis, structure-activity relationship of novel substituted 4H-chromen-1,2,3,4-tetrahydropyrimidine-5-carboxylates as potential anti-mycobacterial and anticancer agents. Bioorganic & medicinal chemistry letters, 2011, May-15, Volume: 21, Issue:10 Topics: Anti-Bacterial Agents; Antineoplastic Agents; Carboxylic Acids; Cell Line, Tumor; Cell Survival; Chromans; Drug Screening Assays, Antitumor; HeLa Cells; Humans; Molecular Structure; Mycobacterium tuberculosis; Pyrimidines; Structure-Activity Relationship	2011
Antimycobacterial activity of novel 1,2,4-oxadiazole-pyranopyridine/chromene hybrids generated by chemoselective 1,3-dipolar cycloadditions of nitrile oxides. Bioorganic & medicinal chemistry, 2011, Jun-01, Volume: 19, Issue:11 Topics: Antibiotics, Antitubercular; Benzopyrans; Microbial Sensitivity Tests; Molecular Conformation; Mycobacterium tuberculosis; Nitriles; Oxadiazoles; Oxides; Pyridines; Structure-Activity Relationship	2011
FDA-approved drug labeling for the study of drug-induced liver injury. Drug discovery today, 2011, Volume: 16, Issue:15-16 Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration	2011
Synthesis and antimycobacterial activity of highly functionalized tetrahydro-4(1H)-pyridinones. Bioorganic & medicinal chemistry letters, 2011, Jul-01, Volume: 21, Issue:13 Topics: Anti-Bacterial Agents; Crystallography, X-Ray; Microbial Sensitivity Tests; Models, Molecular; Mycobacterium tuberculosis; Pyridones	2011
A facile four-component sequential protocol in the expedient synthesis of novel 2-aryl-5-methyl-2,3-dihydro-1H-3-pyrazolones in water and their antitubercular evaluation. European journal of medicinal chemistry, 2011, Volume: 46, Issue:9 Topics: Antitubercular Agents; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Models, Molecular; Mycobacterium tuberculosis; Pyrazolones; Water	2011
Synthesis of 3-heteroarylthioquinoline derivatives and their in vitro antituberculosis and cytotoxicity studies. European journal of medicinal chemistry, 2011, Volume: 46, Issue:10 Topics: Animals; Antitubercular Agents; Humans; Mice; Microbial Sensitivity Tests; Models, Molecular; Mycobacterium tuberculosis; NIH 3T3 Cells; Quinolines; Structure-Activity Relationship; Thiadiazoles; Tuberculosis	2011
A facile synthesis of carbocycle-fused mono and bis-1,2,3-selenadiazoles and their antimicrobial and antimycobacterial studies. European journal of medicinal chemistry, 2011, Volume: 46, Issue:11 Topics: Anti-Bacterial Agents; Azoles; Candida albicans; Chemistry Techniques, Synthetic; Microbial Sensitivity Tests; Mycobacterium tuberculosis	2011
Camphorsulfonic acid catalysed facile tandem double Friedlander annulation protocol for the synthesis of phenoxy linked bisquinoline derivatives and discovery of antitubercular agents. Bioorganic & medicinal chemistry letters, 2012, Feb-15, Volume: 22, Issue:4 Topics: Animals; Antitubercular Agents; Camphor; Catalysis; Chemistry Techniques, Synthetic; Mice; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Phenols; Quinolines; Structure-Activity Relationship	2012
Anti-mycobacterial activities of some cationic and anionic calix[4]arene derivatives. Bioorganic & medicinal chemistry, 2012, Mar-15, Volume: 20, Issue:6 Topics: 2,2'-Dipyridyl; Anions; Antitubercular Agents; Calixarenes; Guanidine; Humans; Inhibitory Concentration 50; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Phenols; Quaternary Ammonium Compounds; Tuberculosis	2012
Compounds of Alpinia katsumadai as potential efflux inhibitors in Mycobacterium smegmatis. Bioorganic & medicinal chemistry, 2012, Apr-15, Volume: 20, Issue:8 Topics: Alpinia; Antibiotics, Antitubercular; Antitubercular Agents; Diarylheptanoids; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium smegmatis; Plant Extracts; Seeds	2012
Synthesis of benzimidazolyl-1,3,4-oxadiazol-2ylthio-N-phenyl (benzothiazolyl) acetamides as antibacterial, antifungal and antituberculosis agents. European journal of medicinal chemistry, 2012, Volume: 53 Topics: Antifungal Agents; Antitubercular Agents; Bacteria; Benzothiazoles; Chemistry Techniques, Synthetic; Fungi; Microbial Sensitivity Tests; Mycobacterium tuberculosis	2012
A solvent free, four-component synthesis and 1,3-dipolar cycloaddition of 4(H)-pyrans with nitrile oxides: synthesis and discovery of antimycobacterial activity of enantiomerically pure 1,2,4-oxadiazoles. European journal of medicinal chemistry, 2012, Volume: 53 Topics: Anti-Bacterial Agents; Chemistry Techniques, Synthetic; Drug Discovery; Drug Resistance, Bacterial; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Nitriles; Oxadiazoles; Oxides; Piperidines; Pyrans; Stereoisomerism	2012
Development of antimycobacterial tetrahydrothieno[2,3-c]pyridine-3-carboxamides and hexahydrocycloocta[b]thiophene-3-carboxamides: Molecular modification from known antimycobacterial lead. European journal of medicinal chemistry, 2014, Apr-09, Volume: 76 Topics: Antitubercular Agents; Drug Design; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Structure-Activity Relationship; Thiophenes	2014
Synthesis and antimycobacterial activities of some new thiazolylhydrazone derivatives. Bioorganic & medicinal chemistry letters, 2014, Apr-01, Volume: 24, Issue:7 Topics: Anti-Bacterial Agents; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Humans; Hydrazones; Microbial Sensitivity Tests; Molecular Docking Simulation; Molecular Structure; Mycobacterium tuberculosis; Structure-Activity Relationship; Thiazoles	2014
Design, synthesis and anti-mycobacterial activity of 1,2,3,5-tetrasubstituted pyrrolyl-N-acetic acid derivatives. European journal of medicinal chemistry, 2014, Sep-12, Volume: 84 Topics: Acetates; Anti-Bacterial Agents; Dose-Response Relationship, Drug; Drug Design; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Pyrroles; Structure-Activity Relationship	2014
Synthesis and anti-mycobacterial activity of 2-chloronicotinaldehydes based novel 1H-1,2,3-triazolylbenzohydrazides. Bioorganic & medicinal chemistry letters, 2015, Jun-01, Volume: 25, Issue:11 Topics: Aldehydes; Animals; Antitubercular Agents; Cell Line; Hydrazines; Mice; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis	2015
Synthesis and biological evaluation of phaitanthrin congeners as anti-mycobacterial agents. Bioorganic & medicinal chemistry letters, 2015, Sep-15, Volume: 25, Issue:18 Topics: Antitubercular Agents; Dose-Response Relationship, Drug; Enoyl-(Acyl-Carrier-Protein) Reductase (NADH); Enzyme Inhibitors; Indoles; Microbial Sensitivity Tests; Models, Molecular; Molecular Structure; Mycobacterium tuberculosis; Quinazolinones; Structure-Activity Relationship	2015
Guanidinium compounds with sub-micromolar activities against Mycobacterium tuberculosis. Synthesis, characterization and biological evaluations. Bioorganic & medicinal chemistry, 2015, Sep-01, Volume: 23, Issue:17 Topics: Antitubercular Agents; Guanidine; Humans; Models, Molecular; Mycobacterium tuberculosis; Tuberculosis	2015
Design of novel dispirooxindolopyrrolidine and dispirooxindolopyrrolothiazole derivatives as potential antitubercular agents. Bioorganic & medicinal chemistry letters, 2015, Oct-01, Volume: 25, Issue:19 Topics: Animals; Antitubercular Agents; Cell Line; Cell Survival; Dose-Response Relationship, Drug; Drug Design; Mice; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Pyrrolidines; Spiro Compounds; Structure-Activity Relationship; Thiazoles	2015
New INH-pyrazole analogs: Design, synthesis and evaluation of antitubercular and antibacterial activity. Bioorganic & medicinal chemistry letters, 2015, Dec-01, Volume: 25, Issue:23 Topics: Anti-Bacterial Agents; Antitubercular Agents; Bacteria; Binding Sites; Drug Design; Inhibitory Concentration 50; Isoniazid; Microbial Sensitivity Tests; Models, Molecular; Molecular Docking Simulation; Molecular Structure; Mycobacterium tuberculosis; Pyrazoles	2015
Design of new phenothiazine-thiadiazole hybrids via molecular hybridization approach for the development of potent antitubercular agents. European journal of medicinal chemistry, 2015, Dec-01, Volume: 106 Topics: Animals; Antitubercular Agents; Cell Survival; Chlorocebus aethiops; Dose-Response Relationship, Drug; Drug Design; Escherichia coli; Microbial Sensitivity Tests; Molecular Docking Simulation; Molecular Structure; Mycobacterium tuberculosis; Phenothiazines; Pseudomonas aeruginosa; Staphylococcus aureus; Structure-Activity Relationship; Thiadiazoles; Vero Cells	2015
Synthesis, antimycobacterial screening and ligand-based molecular docking studies on novel pyrrole derivatives bearing pyrazoline, isoxazole and phenyl thiourea moieties. European journal of medicinal chemistry, 2016, Jan-01, Volume: 107 Topics: Anti-Bacterial Agents; Antitubercular Agents; Bacterial Proteins; Chemistry Techniques, Synthetic; Drug Evaluation, Preclinical; Enzyme Inhibitors; Escherichia coli; Humans; Isoxazoles; Ligands; Microbial Sensitivity Tests; Molecular Docking Simulation; Mycobacterium tuberculosis; Oxidoreductases; Pyrroles; Staphylococcus aureus; Thiourea	2016
Benzo[d]thiazol-2-yl(piperazin-1-yl)methanones as new anti-mycobacterial chemotypes: Design, synthesis, biological evaluation and 3D-QSAR studies. European journal of medicinal chemistry, 2016, Jun-30, Volume: 116 Topics: Animals; Antitubercular Agents; Chemistry Techniques, Synthetic; Drug Design; Mice; Microbial Sensitivity Tests; Models, Molecular; Molecular Conformation; Mycobacterium tuberculosis; Piperazine; Piperazines; Quantitative Structure-Activity Relationship; RAW 264.7 Cells	2016
Synthesis, biological evaluation and structure-activity relationship of 2-styrylquinazolones as anti-tubercular agents. Bioorganic & medicinal chemistry letters, 2016, 06-01, Volume: 26, Issue:11 Topics: Antitubercular Agents; Cell Survival; Dose-Response Relationship, Drug; HEK293 Cells; Humans; Microbial Sensitivity Tests; Molecular Docking Simulation; Molecular Structure; Mycobacterium tuberculosis; Quinazolines; Structure-Activity Relationship	2016
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships. Bioorganic & medicinal chemistry letters, 2016, 08-15, Volume: 26, Issue:16 Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone	2016
Design, development of new synthetic methodology, and biological evaluation of substituted quinolines as new anti-tubercular leads. Bioorganic & medicinal chemistry letters, 2016, 12-15, Volume: 26, Issue:24 Topics: Antitubercular Agents; Dose-Response Relationship, Drug; Drug Design; HEK293 Cells; Humans; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Quinolines; Structure-Activity Relationship; Tuberculosis	2016
Synthesis, biological evaluation and in silico molecular modeling of pyrrolyl benzohydrazide derivatives as enoyl ACP reductase inhibitors. European journal of medicinal chemistry, 2017, Jan-27, Volume: 126 Topics: Anti-Bacterial Agents; Bacteria; Binding Sites; Cell Line, Tumor; Chemistry Techniques, Synthetic; Computer Simulation; Drug Design; Enoyl-(Acyl-Carrier-Protein) Reductase (NADH); Enzyme Inhibitors; Humans; Microbial Sensitivity Tests; Molecular Docking Simulation; Protein Conformation; Pyrroles	2017
Synthesis, screening and docking analysis of hispolon analogs as potential antitubercular agents. Bioorganic & medicinal chemistry letters, 2017, 01-01, Volume: 27, Issue:1 Topics: Antitubercular Agents; Catechols; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Microbial Sensitivity Tests; Molecular Docking Simulation; Molecular Structure; Mycobacterium tuberculosis; Structure-Activity Relationship	2017
A robust synthesis of functionalized 2H-indazoles via solid state melt reaction (SSMR) and their anti-tubercular activity. Bioorganic & medicinal chemistry letters, 2017, 04-01, Volume: 27, Issue:7 Topics: Antitubercular Agents; Ciprofloxacin; Ethambutol; Indazoles; Isoniazid; Mycobacterium tuberculosis; Rifampin; Structure-Activity Relationship	2017
Synthesis and antimycobacterial activity of 1-(β-d-Ribofuranosyl)-4-coumarinyloxymethyl- / -coumarinyl-1,2,3-triazole. European journal of medicinal chemistry, 2018, Apr-25, Volume: 150 Topics: Anti-Bacterial Agents; Cell Line; Cell Survival; Dose-Response Relationship, Drug; Humans; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Structure-Activity Relationship; Triazoles	2018
Benzo[d]thiazole-2-carbanilides as new anti-TB chemotypes: Design, synthesis, biological evaluation, and structure-activity relationship. European journal of medicinal chemistry, 2018, Jul-15, Volume: 155 Topics: Animals; Antitubercular Agents; Carbanilides; Cell Survival; Dose-Response Relationship, Drug; Drug Design; Mice; Microbial Sensitivity Tests; Molecular Docking Simulation; Molecular Structure; Mycobacterium tuberculosis; RAW 264.7 Cells; Structure-Activity Relationship; Thiazoles	2018
Design, synthesis, molecular-docking and antimycobacterial evaluation of some novel 1,2,3-triazolyl xanthenones. MedChemComm, 2017, Mar-01, Volume: 8, Issue:3 Topics:	2017
Conjugation of a 5-nitrofuran-2-oyl moiety to aminoalkylimidazoles produces non-toxic nitrofurans that are efficacious in vitro and in vivo against multidrug-resistant Mycobacterium tuberculosis. European journal of medicinal chemistry, 2018, Sep-05, Volume: 157 Topics: Antitubercular Agents; Dose-Response Relationship, Drug; Drug Resistance, Multiple, Bacterial; Imidazoles; Molecular Structure; Mycobacterium tuberculosis; Nitrofurans; Structure-Activity Relationship; Tuberculosis, Multidrug-Resistant	2018
Synthesis and biological evaluation of 1H-pyrrolo[2,3-d]pyrimidine-1,2,3-triazole derivatives as novel anti-tubercular agents. Bioorganic & medicinal chemistry letters, 2019, 01-15, Volume: 29, Issue:2 Topics: Antitubercular Agents; Dose-Response Relationship, Drug; Microbial Sensitivity Tests; Molecular Docking Simulation; Molecular Structure; Mycobacterium tuberculosis; Pyrimidines; Pyrroles; Structure-Activity Relationship; Triazoles	2019
Synthesis of novel morpholine, thiomorpholine and N-substituted piperazine coupled 2-(thiophen-2-yl)dihydroquinolines as potent inhibitors of Mycobacterium tuberculosis. European journal of medicinal chemistry, 2019, Feb-15, Volume: 164 Topics: Antitubercular Agents; Humans; Magnetic Resonance Spectroscopy; Mass Spectrometry; Microbial Sensitivity Tests; Morpholines; Mycobacterium tuberculosis; Piperazine; Quinolines; Structure-Activity Relationship	2019
Synthesis and evaluation of novel substituted 1,2,3-triazolyldihydroquinolines as promising antitubercular agents. Bioorganic & medicinal chemistry letters, 2019, 02-15, Volume: 29, Issue:4 Topics: Antitubercular Agents; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Quinolines; Triazoles	2019
Expansion of a novel lead targeting M. tuberculosis DHFR as antitubercular agents. Bioorganic & medicinal chemistry, 2019, 04-01, Volume: 27, Issue:7 Topics: Antitubercular Agents; Dose-Response Relationship, Drug; Enzyme Inhibitors; Humans; Indoles; Microbial Sensitivity Tests; Models, Molecular; Molecular Structure; Mycobacterium tuberculosis; Structure-Activity Relationship; Tetrahydrofolate Dehydrogenase	2019
5-Chloro-2-thiophenyl-1,2,3-triazolylmethyldihydroquinolines as dual inhibitors of Mycobacterium tuberculosis and influenza virus: Synthesis and evaluation. Bioorganic & medicinal chemistry letters, 2019, 09-15, Volume: 29, Issue:18 Topics: Antitubercular Agents; Antiviral Agents; Dose-Response Relationship, Drug; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Orthomyxoviridae; Structure-Activity Relationship	2019
Development of (4-methoxyphenyl)-1H-tetrazol-5-amine regioisomers as a new class of selective antitubercular agents. European journal of medicinal chemistry, 2020, Jan-15, Volume: 186 Topics: Amines; Antitubercular Agents; Cell Death; Cell Line; Dose-Response Relationship, Drug; Humans; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium; Structure-Activity Relationship; Tetrazoles	2020
Usnic Acid Enaminone-Coupled 1,2,3-Triazoles as Antibacterial and Antitubercular Agents. Journal of natural products, 2020, 01-24, Volume: 83, Issue:1 Topics: Anti-Bacterial Agents; Antitubercular Agents; Bacillus subtilis; Benzofurans; Lichens; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Triazoles	2020
Novel benzimidazole-acrylonitrile hybrids and their derivatives: Design, synthesis and antimycobacterial activity. European journal of medicinal chemistry, 2020, Feb-15, Volume: 188 Topics: Acrylonitrile; Anti-Bacterial Agents; Benzimidazoles; Dose-Response Relationship, Drug; Drug Design; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Structure-Activity Relationship	2020
Novel isoniazid embedded triazole derivatives: Synthesis, antitubercular and antimicrobial activity evaluation. Bioorganic & medicinal chemistry letters, 2020, 10-01, Volume: 30, Issue:19 Topics: Animals; Antifungal Agents; Antitubercular Agents; Aspergillus niger; Bacterial Proteins; Drug Design; Gram-Negative Bacteria; Isoniazid; Mice; Microbial Sensitivity Tests; Molecular Docking Simulation; Mycobacterium tuberculosis; Oxidoreductases; Protein Binding; RAW 264.7 Cells; Triazoles	2020
Design and synthesis of purine connected piperazine derivatives as novel inhibitors of Mycobacterium tuberculosis. Bioorganic & medicinal chemistry letters, 2020, 11-15, Volume: 30, Issue:22 Topics: Antitubercular Agents; Dose-Response Relationship, Drug; Drug Design; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Piperazine; Purines; Structure-Activity Relationship	2020
Design and synthesis of new indanol-1,2,3-triazole derivatives as potent antitubercular and antimicrobial agents. Bioorganic & medicinal chemistry letters, 2020, 11-15, Volume: 30, Issue:22 Topics: Antitubercular Agents; Dose-Response Relationship, Drug; Drug Design; HEK293 Cells; Humans; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Structure-Activity Relationship; Triazoles	2020
Synthesis and biological evaluation of anti-tubercular activity of Schiff bases of 2-Amino thiazoles. Bioorganic & medicinal chemistry letters, 2020, 12-15, Volume: 30, Issue:24 Topics: Amination; Antitubercular Agents; Humans; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Schiff Bases; Thiazoles; Tuberculosis	2020
Design, synthesis and molecular docking studies of imidazole and benzimidazole linked ethionamide derivatives as inhibitors of InhA and antituberculosis agents. Bioorganic & medicinal chemistry letters, 2022, 03-15, Volume: 60 Topics: Antitubercular Agents; Benzimidazoles; Dose-Response Relationship, Drug; Drug Design; Ethionamide; Humans; Imidazoles; Inhibins; Microbial Sensitivity Tests; Molecular Docking Simulation; Molecular Structure; Mycobacterium tuberculosis; Structure-Activity Relationship	2022
Susceptibility of Mycobacterium kansasii to ethambutol and its combination with rifamycins, ciprofloxacin and isoniazid. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1992, Volume: 11, Issue:1 Topics: Ciprofloxacin; Drug Resistance, Microbial; Drug Synergism; Ethambutol; Isoniazid; Nontuberculous Mycobacteria; Rifamycins	1992
[Intra-macrophagic activity of antibiotics combinations against Mycobacterium marinum]. Pathologie-biologie, 1991, Volume: 39, Issue:5 Topics: Anti-Infective Agents; Antitubercular Agents; Ciprofloxacin; Clarithromycin; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Erythromycin; Ethambutol; Fluoroquinolones; Humans; In Vitro Techniques; Macrophages; Minocycline; Mycobacterium; Quinolones; Rifabutin; Rifamycins	1991
Successful treatment of acquired immunodeficiency syndrome-related Mycobacterium avium complex disease with a multiple drug regimen including amikacin. Archives of internal medicine, 1991, Volume: 151, Issue:3 Topics: Acquired Immunodeficiency Syndrome; Adult; Amikacin; Antitubercular Agents; Ciprofloxacin; Clofazimine; Drug Therapy, Combination; Ethambutol; Humans; Male; Middle Aged; Mycobacterium avium-intracellulare Infection; Rifampin	1991
In vitro susceptibility of Mycobacterium avium complex to the new fluoroquinolone sparfloxacin (CI-978; AT-4140) and comparison with ciprofloxacin. Antimicrobial agents and chemotherapy, 1990, Volume: 34, Issue:12 Topics: Acquired Immunodeficiency Syndrome; Anti-Infective Agents; Ciprofloxacin; Drug Synergism; Ethambutol; Fluoroquinolones; Microbial Sensitivity Tests; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Rifampin	1990
Treatment of disseminated Mycobacterium avium complex infection in AIDS with amikacin, ethambutol, rifampin, and ciprofloxacin. California Collaborative Treatment Group. Annals of internal medicine, 1990, Sep-01, Volume: 113, Issue:5 Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Amikacin; Chemical and Drug Induced Liver Injury; Ciprofloxacin; Drug Therapy, Combination; Ethambutol; Female; Humans; Infusions, Intravenous; Male; Mycobacterium avium-intracellulare Infection; Rifampin; Vomiting	1990
In-vitro synergistic activity between ethambutol and fluorinated quinolones against Mycobacterium avium complex. The Journal of antimicrobial chemotherapy, 1989, Volume: 24, Issue:3 Topics: Anti-Infective Agents; Ciprofloxacin; Drug Interactions; Drug Synergism; Ethambutol; Humans; Microbial Sensitivity Tests; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Norfloxacin; Ofloxacin	1989
In vitro activity of ciprofloxacin in combination with standard antituberculous drugs against mycobacterium tuberculosis. Tubercle, 1988, Volume: 69, Issue:3 Topics: Antitubercular Agents; Ciprofloxacin; Ethambutol; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Streptomycin	1988
Hepatotoxicity associated with acetaminophen usage in patients receiving multiple drug therapy for tuberculosis. Chest, 1994, Volume: 105, Issue:2 Topics: Acetaminophen; Adult; Capreomycin; Ciprofloxacin; Drug Combinations; Drug Overdose; Ethambutol; Female; Humans; Isoniazid; Liver; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis; Tuberculosis, Lymph Node; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary	1994
Radiometric susceptibility testing of Mycobacterium xenopi. Journal of chemotherapy (Florence, Italy), 1995, Volume: 7, Issue:2 Topics: Amikacin; Ciprofloxacin; Ethambutol; Microbial Sensitivity Tests; Nontuberculous Mycobacteria; Radiometry; Rifabutin; Rifampin; Streptomycin	1995
Rifampin-resistant Mycobacterium kansasii. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1994, Volume: 18, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Amikacin; Antitubercular Agents; Ciprofloxacin; Clinical Protocols; Drug Resistance, Microbial; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Pyrazinamide; Pyridoxine; Rifampin; Streptomycin; Texas; Treatment Outcome; Tuberculosis	1994
Low serum levels of oral antimycobacterial agents in patients with disseminated Mycobacterium avium complex disease. The Journal of infectious diseases, 1993, Volume: 168, Issue:6 Topics: Administration, Oral; Adolescent; Adult; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Ciprofloxacin; Clofazimine; Drug Monitoring; Ethambutol; Female; Humans; Male; Microbial Sensitivity Tests; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Prospective Studies; Rifampin	1993
Susceptibility of Mycobacterium malmoense to antibacterial drugs and drug combinations. Antimicrobial agents and chemotherapy, 1993, Volume: 37, Issue:6 Topics: Amikacin; Anti-Bacterial Agents; Ciprofloxacin; Clarithromycin; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Ethambutol; Humans; Microbial Sensitivity Tests; Mycobacterium; Rifabutin; Rifampin; Rifamycins	1993
A cutaneous lesion in a patient with AIDS: an unusual presentation of infection due to Mycobacterium avium complex. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1993, Volume: 16, Issue:4 Topics: Administration, Oral; Adult; AIDS-Related Opportunistic Infections; Ciprofloxacin; Clarithromycin; Drug Therapy, Combination; Ethambutol; Humans; Male; Mycobacterium avium; Mycobacterium avium-intracellulare Infection; Rifampin; Skin Diseases, Bacterial	1993
Mycobacterium avium-intracellulare complex pneumonia in a non-HIV-infected individual: an increasingly recognized disease. Southern medical journal, 1996, Volume: 89, Issue:5 Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitubercular; Antitubercular Agents; Ciprofloxacin; Clarithromycin; Drug Therapy, Combination; Ethambutol; HIV Seronegativity; Humans; Male; Mycobacterium avium-intracellulare Infection; Necrosis; Pneumonia, Bacterial; Pulmonary Atelectasis; Rifampin	1996
The management of mycobacterial infections in HIV seropositive individuals. Jefferiss Wing Therapeutics and Protocols Group. International journal of STD & AIDS, 1996, Volume: 7, Issue:4 Topics: Adrenal Cortex Hormones; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitubercular; Antitubercular Agents; Ciprofloxacin; Clarithromycin; Clofazimine; Drug Therapy, Combination; Ethambutol; HIV Infections; Humans; Isoniazid; Mycobacterium avium-intracellulare Infection; Mycobacterium Infections; Nontuberculous Mycobacteria; Practice Guidelines as Topic; Pyrazinamide; Pyridoxine; Radiography; Rifabutin; Rifampin; Tuberculosis, Meningeal; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary	1996
Evaluation of the post-antibiotic effect of six anti-mycobacterial agents against Mycobacterium avium by the Bactec radiometric method. The Journal of antimicrobial chemotherapy, 1997, Volume: 40, Issue:1 Topics: Amikacin; Antitubercular Agents; Cell Division; Ciprofloxacin; Clarithromycin; Drug Therapy, Combination; Ethambutol; Isoniazid; Microbial Sensitivity Tests; Mycobacterium avium; Radiometry; Rifampin	1997
A rapid drug susceptibility test for Mycobacterium tuberculosis using the hybridization protection assay. The Journal of antimicrobial chemotherapy, 1997, Volume: 40, Issue:2 Topics: Anti-Infective Agents; Antitubercular Agents; Ciprofloxacin; Colony Count, Microbial; Ethambutol; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Nucleic Acid Hybridization; Streptomycin; Time Factors	1997
Electron microscopic analysis of Mycobacterium avium complex isolates exposed to ciprofloxacin, rifabutin, ethambutol and clarithromycin. The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 1997, Volume: 1, Issue:3 Topics: Antitubercular Agents; Ciprofloxacin; Clarithromycin; Dose-Response Relationship, Drug; Ethambutol; Humans; Microbial Sensitivity Tests; Microscopy, Electron; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Rifabutin	1997
Successful treatment of disseminated Mycobacterium simiae infection in AIDS patients. Scandinavian journal of infectious diseases, 1998, Volume: 30, Issue:2 Topics: Adolescent; Adult; AIDS-Related Opportunistic Infections; Anti-Infective Agents; Bacteremia; Ciprofloxacin; Clarithromycin; Disease-Free Survival; Drug Therapy, Combination; Ethambutol; Female; Humans; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Prognosis; Retrospective Studies; Treatment Outcome	1998
Treatment of disseminated Mycobacterium genavense infection in a murine model with ciprofloxacin, amikacin, ethambutol, clarithromycin and rifabutin. The Journal of antimicrobial chemotherapy, 1998, Volume: 42, Issue:4 Topics: Amikacin; Animals; Anti-Bacterial Agents; Ciprofloxacin; Clarithromycin; Drug Therapy, Combination; Ethambutol; Female; Mice; Mice, Inbred C57BL; Mycobacterium; Mycobacterium Infections; Rifabutin; Spleen	1998
Evaluation of a bacteriophage-based assay (phage amplified biologically assay) as a rapid screen for resistance to isoniazid, ethambutol, streptomycin, pyrazinamide, and ciprofloxacin among clinical isolates of Mycobacterium tuberculosis. Journal of clinical microbiology, 1999, Volume: 37, Issue:11 Topics: Antitubercular Agents; Ciprofloxacin; Drug Resistance, Microbial; Ethambutol; Evaluation Studies as Topic; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacteriophages; Mycobacterium tuberculosis; Phenotype; Pyrazinamide; Streptomycin; Tuberculosis	1999
Mycobacterium ulcerans infection (Buruli ulcer): first reported case in a traveler. The American journal of tropical medicine and hygiene, 1999, Volume: 61, Issue:5 Topics: Adult; Africa; Anti-Bacterial Agents; Antibiotics, Antitubercular; Antitubercular Agents; Ciprofloxacin; Clarithromycin; Cloxacillin; Ethambutol; Humans; Leg Ulcer; Male; Metronidazole; Mycobacterium Infections, Nontuberculous; Mycobacterium ulcerans; Penicillins; Rifampin; Skin Diseases, Bacterial; Skin Transplantation; Travel; Trimethoprim, Sulfamethoxazole Drug Combination; Virulence	1999
[Breast abscess and pregnancy toxemia revealing multidrug resistant tuberculosis]. Revue des maladies respiratoires, 1999, Volume: 16, Issue:5 Topics: Abscess; Adult; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Antitubercular Agents; Breast Diseases; Bronchoscopy; Cesarean Section; Ciprofloxacin; Drug Therapy, Combination; Eclampsia; Ethambutol; Female; Follow-Up Studies; Humans; Infant, Newborn; Pregnancy; Pregnancy Complications, Infectious; Pyrazinamide; Radiography, Thoracic; Time Factors; Tomography, X-Ray Computed; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary	1999
A retrospective study of the addition of ciprofloxacin to clarithromycin and ethambutol in the treatment of disseminated Mycobacterium avium complex infection. International journal of STD & AIDS, 1999, Volume: 10, Issue:12 Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antitubercular Agents; CD4 Lymphocyte Count; Ciprofloxacin; Clarithromycin; Cohort Studies; Drug Therapy, Combination; Ethambutol; HIV Infections; Humans; Longitudinal Studies; Male; Mycobacterium avium-intracellulare Infection; Retrospective Studies; Time Factors	1999
Evaluation of Etest for susceptibility testing of Mycobacterium tuberculosis. Journal of clinical microbiology, 2000, Volume: 38, Issue:10 Topics: Agar; Anti-Infective Agents; Antitubercular Agents; Ciprofloxacin; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Ofloxacin; Rifampin; Streptomycin	2000
MAC management. PI perspective, 1996, Issue:No 20 Topics: Acquired Immunodeficiency Syndrome; Amikacin; Antitubercular Agents; Ciprofloxacin; Clarithromycin; Clofazimine; Drug Interactions; Drug Therapy, Combination; Ethambutol; Humans; Mycobacterium avium-intracellulare Infection; Rifabutin; Rifampin; Tuberculin Test; Zidovudine	1996
[Skin nodules and ulcers of the limbs in a patient with rheumatoid arthritis]. Deutsche medizinische Wochenschrift (1946), 2002, Apr-05, Volume: 127, Issue:14 Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antirheumatic Agents; Antitubercular Agents; Arthritis, Rheumatoid; Biopsy; Ciprofloxacin; Clarithromycin; Diagnosis, Differential; Drug Therapy, Combination; Ethambutol; Extremities; Glucocorticoids; Humans; Immunocompromised Host; Male; Methotrexate; Middle Aged; Mycobacterium Infections, Nontuberculous; Mycobacterium marinum; Prednisolone; Skin Diseases, Bacterial; Skin Ulcer; Vasculitis	2002
[Two cases of pulmonary infection by Mycobacterium abscessus in which drug susceptibility testing results conflicted with clinical courses]. Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society, 2005, Volume: 43, Issue:4 Topics: Aged; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Drug Therapy, Combination; Ethambutol; Humans; Male; Microbial Sensitivity Tests; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Radiography; Rifampin	2005
Identification of Lactobacillus ruminus SPM0211 isolated from healthy Koreans and its antimicrobial activity against some pathogens. Archives of pharmacal research, 2005, Volume: 28, Issue:6 Topics: Adult; Base Sequence; Ciprofloxacin; DNA Fingerprinting; Drug Resistance, Bacterial; Enterococcus; Ethambutol; Feces; Humans; Korea; Lactobacillus; Microbial Sensitivity Tests; Molecular Sequence Data; Probiotics; Random Amplified Polymorphic DNA Technique; Rifampin; Staphylococcus aureus; Streptomycin; Time Factors; Vancomycin	2005
Determination of in vitro synergy when three antimicrobial agents are combined against Mycobacterium tuberculosis. International journal of antimicrobial agents, 2005, Volume: 26, Issue:4 Topics: Anti-Bacterial Agents; Antibiotics, Antitubercular; Antitubercular Agents; Ciprofloxacin; Clarithromycin; Drug Synergism; Ethambutol; Fluoroquinolones; Humans; Isoniazid; Levofloxacin; Microbial Sensitivity Tests; Minocycline; Mycobacterium tuberculosis; Ofloxacin; Rifampin; Tuberculosis	2005
Mycobacterium kansasii: antibiotic susceptibility and PCR-restriction analysis of clinical isolates. Journal of medical microbiology, 2005, Volume: 54, Issue:Pt 10 Topics: Amikacin; Anti-Bacterial Agents; Brazil; Ciprofloxacin; Clarithromycin; Clofazimine; Cycloserine; DNA Fingerprinting; DNA, Bacterial; Doxycycline; Drug Resistance, Bacterial; Ethambutol; Ethionamide; Genotype; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium Infections, Nontuberculous; Mycobacterium kansasii; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Rifabutin; Rifampin; Streptomycin	2005
Pulmonary Mycobacterium kansasii infection in Israel, 1999-2004: clinical features, drug susceptibility, and outcome. Chest, 2006, Volume: 129, Issue:3 Topics: Adult; Antibiotics, Antitubercular; Ciprofloxacin; Clarithromycin; Cycloserine; Ethambutol; Ethionamide; Female; Humans; Israel; Lung Diseases; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium Infections, Nontuberculous; Mycobacterium kansasii; Ofloxacin; Prognosis; Rifampin	2006
[Cervical lymphadenitis due to Mycobacterium avium in an immunocompetent adult]. Enfermedades infecciosas y microbiologia clinica, 2007, Volume: 25, Issue:2 Topics: Accidents, Traffic; Adolescent; Ciprofloxacin; Clarithromycin; Ethambutol; Humans; Immunocompetence; Lymphadenitis; Male; Mouth; Mycobacterium avium-intracellulare Infection; Neck; Wound Infection	2007
[Mycobacterium avium infection in a renal transplant recipient]. Enfermedades infecciosas y microbiologia clinica, 2007, Volume: 25, Issue:4 Topics: Adult; Anti-Bacterial Agents; Antitubercular Agents; Biopsy; Ciprofloxacin; Clarithromycin; Diagnosis, Differential; Ethambutol; Hepatitis; Humans; Immunocompromised Host; Immunosuppressive Agents; Kidney Transplantation; Male; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Tuberculosis, Hepatic; Typhlitis	2007
Postoperative Mycobacterium abscessus nodular conjunctivitis. Clinical & experimental ophthalmology, 2008, Volume: 36, Issue:4 Topics: Aged; Anti-Bacterial Agents; Cataract Extraction; Ciprofloxacin; Clarithromycin; Conjunctivitis; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Humans; Male; Mycobacterium Infections, Nontuberculous; Postoperative Complications; Recurrence	2008
[Severe course of a rare non-tuberculous Mycobacteriosis (M. haemophilum) of the hand - case report and strategic comments]. Handchirurgie, Mikrochirurgie, plastische Chirurgie : Organ der Deutschsprachigen Arbeitsgemeinschaft fur Handchirurgie : Organ der Deutschsprachigen Arbeitsgemeinschaft fur Mikrochirurgie der Peripheren Nerven und Gefasse : Organ der V..., 2008, Volume: 40, Issue:5 Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Clarithromycin; Debridement; Drug Therapy, Combination; Ethambutol; Female; Follow-Up Studies; Hand; Humans; Middle Aged; Mycobacterium haemophilum; Mycobacterium Infections; Rifabutin; Synovitis; Time Factors; Treatment Outcome	2008
Molecular detection of mutations associated with first- and second-line drug resistance compared with conventional drug susceptibility testing of Mycobacterium tuberculosis. Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:5 Topics: Amikacin; Antitubercular Agents; Bacterial Proteins; Capreomycin; Ciprofloxacin; Ethambutol; Isoniazid; Kanamycin; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Ofloxacin; Pyrazinamide; Rifampin	2011
A simple and economical in-house phage technique for the rapid detection of rifampin, isoniazid, ethambutol, streptomycin, and ciprofloxacin drug resistance in Mycobacterium tuberculosis, directly on decontaminated sputum samples. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2012, Volume: 16, Issue:5 Topics: Adolescent; Adult; Aged; Antibiotics, Antitubercular; Ciprofloxacin; Ethambutol; Female; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Microbial Viability; Middle Aged; Mycobacteriophages; Mycobacterium tuberculosis; Rifampin; Sensitivity and Specificity; Sputum; Streptomycin; Tuberculosis, Multidrug-Resistant; Virus Replication; Young Adult	2012
In-house, simple & economical phage technique for rapid detection of rifampicin, isoniazid, ethambutol, streptomycin & ciprofloxacin drug resistance using Mycobacterium tuberculosis isolates. The Indian journal of medical research, 2012, Volume: 135, Issue:5 Topics: Antitubercular Agents; Bacteriophages; Ciprofloxacin; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Sensitivity and Specificity; Streptomycin; Tuberculosis, Multidrug-Resistant	2012
Disseminated Mycobacterium celatum disease with prolonged pulmonary involvement. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2014, Volume: 26 Topics: Aged; Anti-Bacterial Agents; Azithromycin; Ciprofloxacin; Clarithromycin; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Lung; Lung Diseases; Mycobacterium; Mycobacterium Infections; Pyrazinamide; Radiography	2014
Paradoxical reaction associated with cervical lymph node tuberculosis: predictive factors and therapeutic management. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2017, Volume: 54 Topics: Adult; Anti-Bacterial Agents; Antitubercular Agents; Ciprofloxacin; Disease Management; Ethambutol; Female; Humans; Lymph Nodes; Male; Middle Aged; Retrospective Studies; Treatment Outcome; Tuberculosis, Lymph Node; Young Adult	2017
Cutaneous Mycobacterium gordonae infection in an elderly diabetic returned traveller. Journal of travel medicine, 2017, Sep-01, Volume: 24, Issue:5 Topics: Aged; Anti-Bacterial Agents; Ciprofloxacin; Diabetes Mellitus, Type 2; Diagnosis, Differential; Ethambutol; Humans; Male; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Rifampin; Skin Diseases, Infectious; Travel	2017
Machine learning for classifying tuberculosis drug-resistance from DNA sequencing data. Bioinformatics (Oxford, England), 2018, 05-15, Volume: 34, Issue:10 Topics: Antitubercular Agents; Ciprofloxacin; Ethambutol; Humans; Isoniazid; Machine Learning; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium tuberculosis; Ofloxacin; Pyrazinamide; Rifampin; Sequence Analysis, DNA; Streptomycin; Tuberculosis, Multidrug-Resistant	2018